CEFTAZIDIME IN CYSTIC-FIBROSIS - CLINICAL, MICROBIOLOGICAL AND IMMUNOLOGICAL STUDIES

被引：11
|
作者：
CULLEN, RT
MCCRAE, WM
GOVAN, J
RAEBURN, JA
INGRAM, TM
机构：
[1] UNIV EDINBURGH,DEPT HUMAN GENET,HOST DEF LAB,EDINBURGH EH8 9YL,MIDLOTHIAN,SCOTLAND
[2] UNIV EDINBURGH,DEPT CHILD LIFE & HLTH,EDINBURGH EH8 9YL,MIDLOTHIAN,SCOTLAND
[3] UNIV EDINBURGH,DEPT BACTERIOL,EDINBURGH EH8 9YL,MIDLOTHIAN,SCOTLAND
[4] GLAXO GRP RES LTD,GREENFORD UB6 0HE,MIDDX,ENGLAND
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 1983年 / 12卷
关键词：
D O I：
10.1093/jac/12.suppl_A.369
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：369 / 375
页数：7
相关论文
共 50 条
  • [31] ANIMAL STUDIES OF CYSTIC-FIBROSIS
    TEBBUTT, SJ
    MOLECULAR MEDICINE TODAY, 1995, 1 (07): : 336 - 342
  • [32] CEFTAZIDIME TREATMENT IN CYSTIC-FIBROSIS - RESISTANT ORGANISMS IN SPUTUM AND FECES
    DALZELL, AM
    SUNDERLAND, D
    HART, CA
    HEAF, DP
    THORAX, 1991, 46 (04) : 239 - 241
  • [33] SINGLE DAILY ADMINISTRATION OF CEFTAZIDIME IN CYSTIC-FIBROSIS - PHARMACOKINETICS AND BIOAVAILABILITY
    BOCCAZZI, A
    CROSSIGNANI, RM
    PADOAN, R
    COSTANTINI, D
    GIUNTA, A
    RIVISTA ITALIANA DI PEDIATRIA-ITALIAN JOURNAL OF PEDIATRICS, 1985, 11 (05): : 591 - 591
  • [34] CEFTAZIDIME TREATMENT OF CHRONIC PSEUDOMONAS INFECTION IN PATIENTS WITH CYSTIC-FIBROSIS
    FLUGE, G
    DIGRANES, A
    MICHALSEN, H
    STIRIS, T
    BERGAN, T
    QVIGSTAD, EK
    EUROPEAN JOURNAL OF RESPIRATORY DISEASES, 1987, 71 (04): : 239 - 243
  • [35] CEFTAZIDIME IN TREATMENT OF ACUTE PULMONARY EXACERBATIONS IN PATIENTS WITH CYSTIC-FIBROSIS
    PADOAN, R
    BRIENZA, A
    CROSSIGNANI, RM
    LODI, G
    GIUNTA, A
    ASSAEL, BM
    GRANATA, F
    PASSARELLA, E
    VALLAPERTA, PA
    XERRI, L
    JOURNAL OF PEDIATRICS, 1983, 103 (02): : 320 - 324
  • [36] MICROBIOLOGICAL EFFECTS OF ANTISTAPHYLOCOCCAL COMPOUNDS IN CYSTIC-FIBROSIS PATIENTS
    BAUERNFEIND, A
    HORL, G
    PRZYKLENK, B
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1988, 23 : 173 - 173
  • [37] CEFTAZIDIME IN THE TREATMENT OF PULMONARY EXACERBATIONS IN PATIENTS WITH CYSTIC-FIBROSIS - INVITRO EVALUATION, PHARMACOKINETICS AND CLINICAL EFFICACY
    PADOAN, R
    ASSAEL, BM
    BRIENZA, A
    CAMBISANO, W
    CROSSIGNANI, RM
    GIUNTA, A
    GRANATA, F
    PASSARELLA, E
    VALLAPERTA, P
    XERRI, L
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1983, 9 (8-9) : 661 - 664
  • [38] IMMEDIATE AND PROLONGED CLINICAL EFFICACY OF CEFTAZIDIME VERSUS CEFTAZIDIME PLUS TOBRAMYCIN IN CHRONIC PSEUDOMONAS-AERUGINOSA INFECTION IN CYSTIC-FIBROSIS
    PEDERSEN, SS
    PRESSLER, T
    PEDERSEN, M
    HOIBY, N
    FRIISMOLLER, A
    KOCH, C
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1986, 18 (02) : 133 - 137
  • [39] DOES ACUTE PULMONARY INFECTION ALTER CEFTAZIDIME PHARMACOKINETICS IN CYSTIC-FIBROSIS
    LEEDER, S
    SPINO, M
    ISLES, A
    TESORO, A
    GOLD, R
    MACLEOD, S
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (02) : 254 - 254
  • [40] CEFTAZIDIME FOR THE TREATMENT OF PSEUDOMONAS-AERUGINOSA SUPERINFECTIONS IN CHILDREN WITH CYSTIC-FIBROSIS
    LABBE, A
    SABLAYROLLES, B
    DECHAMPS, C
    SIROT, J
    MARTY, N
    ANNALES DE PEDIATRIE, 1986, 33 (07): : 625 - 628
12345